Geneseeq, Author at Geneseeq Technology Inc. | A Precision Oncology Company

July 14, 2026

Geneseeq Canada Named First Genomic Testing Partner in UHN’s SHERLOCK Study

0 Comments5 Minutes

October 17, 2023

Geneseeq to present four studies at ESMO 2023

0 Comments1 Minute

October 13, 2023

GENESEEQ RECEIVES CHINESE NMPA APPROVAL FOR LUNG CANCER TUMOR MUTATIONAL BURDEN NGS TEST KIT

0 Comments1 Minutes

August 29, 2023

GENESEEQ TO SHARE EIGHT COLLABORATED STUDIES AT WCLC 2023

0 Comments1 Minutes

August 22, 2023

Geneseeq Gains CE Marks for NGS-based Test Kits for Solid Tumors and Hematological Cancer

0 Comments3 Minutes

May 25, 2023

GENESEEQ TO SHOWCASE NEW FINDINGS AT ASCO 2023

0 Comments2 Minutes

May 16, 2023

Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer

0 Comments2 Minutes